Latest Articles

Publication Date
Letter on 'Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)-A Randomised, Controlled Crossover Feeding Study'.

Published: Nov. 25, 2025, midnight
Lack of Scientific Evidence for the Use of Gestrinone in the Treatment of Lipedema: A Systematic Review.

Lipedema is a chronic, progressive disorder marked by the abnormal accumulation of subcutaneous adipose tissue, predominantly in the lower body and almost exclusively affecting women. In recent years, the off-label …

Published: Nov. 19, 2025, midnight
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami

Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami

Published: Nov. 12, 2025, 1:59 p.m.
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 - The Manila Times

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 The Manila Times

Published: Nov. 12, 2025, 1:33 p.m.
S01 E07 - Why weren't women included in clinical trials? - TVO Today

S01 E07 - Why weren't women included in clinical trials? TVO Today

Published: Nov. 11, 2025, 2 p.m.
S01 E07 - Why weren't women included in clinical trials? - TVO

S01 E07 - Why weren't women included in clinical trials? TVO

Published: Nov. 11, 2025, 2 p.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - The Malaysian Reserve

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health The Malaysian Reserve

Published: Nov. 6, 2025, 8:25 p.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - Fidelity

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health Fidelity

Published: Nov. 6, 2025, 4:32 a.m.
HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health - PR Newswire

HMI-115, a Potential First-in-Class Treatment for Endometriosis, Published Proof-of-Concept Phase II Clinical Trial Results in The Lancet Obstetrics, Gynaecology, & Women's Health PR Newswire

Published: Nov. 6, 2025, 4:08 a.m.
Ultrasound-guided ethanol sclerotherapy versus laparoscopic surgery for endometriomas: a randomized clinical trial in a real-world setting.

To compare the efficacy of ultrasound-guided alcohol sclerotherapy versus laparoscopic cystectomy for the management of ovarian endometriomas, focusing on complications, recurrence, pain relief, and healthcare costs.

Published: Nov. 4, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!